Manasa Enja
Overview
Explore the profile of Manasa Enja including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolikonda M, Srinivasan K, Enja M, Sagi V, Lippmann S
Innov Clin Neurosci
. 2018 Jan;
14(9-10):11-12.
PMID: 29344426
No abstract available.
2.
Cherlopalle S, Enja M, Lippmann M, Lippmann S
Prim Care Companion CNS Disord
. 2016 Nov;
18(4).
PMID: 27828699
Adulteration of cocaine with levamisole is common and can induce serious medical complications. Levamisole is an antihelminthic agent originally approved as an immunomodulator in the treatment of autoimmune disorders and...
3.
Narang P, Johnson A, Enja M, Lippmann S
South Med J
. 2016 Oct;
109(10):628-630.
PMID: 27706500
Many psychiatric patients experience pharmaceutical intolerances, and some of them do not derive optimal efficacy from their pharmacotherapies. Clinical problems such as these may result in prolonged dysfunction, adverse consequences,...
4.
Smith E, Narang P, Enja M, Lippmann S
Prim Care Companion CNS Disord
. 2016 Aug;
18(2).
PMID: 27486547
Pharmacotherapy for insomnia in primary care settings can be challenging. Frequently, there are multiple coexisting medical and psychiatric conditions, drug interactions, concern regarding use of habit-forming sleep aids, and paucity...
5.
Smith L, Brar K, Srinivasan K, Enja M, Lippmann S
J Fam Pract
. 2016 Jul;
65(6):380-5.
PMID: 27474819
Without tobacco, tar, ash, or carbon monoxide, e-cigarettes are marketed as "healthier" alternatives to cigarettes. But they are not without risk.
6.
Kolikonda M, Srinivasan K, Enja M, Sagi V, Lippmann S
Innov Clin Neurosci
. 2016 Jun;
13(3-4):23-6.
PMID: 27354925
Treatment-refractory epilepsy remains an important clinical problem. There is considerable recent interest by the public and physicians in using medical marijuana or its derivatives to treat seizures. The endocannabinoid system...
7.
Srinivasan K, Smith L, Enja M, Lippmann S
J Fam Pract
. 2015 Oct;
64(8):452.
PMID: 26485259
No abstract available.
8.
Loganathan M, Enja M, Lippmann S
Innov Clin Neurosci
. 2015 Jul;
12(5-6):38-41.
PMID: 26155377
Forced normalization is the emergence of psychoses following the establishment of seizure control in an uncontrolled epilepsy patient. Two illustrative clinical vignettes are provided about people with epilepsy that was...
9.
Kolikonda M, Cherlopalle S, Enja M, Lippmann S
Innov Clin Neurosci
. 2015 May;
12(3-4):24-6.
PMID: 26000202
Pentazocine is a mixed agonist/antagonist opioid analgesic agent that can induce an atypical myopathy following intramuscular injections. This iatrogenic myopathy is rare, typified by fibrosis, and should be differentiated from...
10.
Lee J, Narang P, Enja M, Lippmann S
Innov Clin Neurosci
. 2015 Apr;
12(1-2):29-31.
PMID: 25852977
Ketamine is an N-methyl-D- aspartate antagonist with rapid antidepressant effects. Research shows that ketamine has a fast onset of reduction in depressive symptoms and shows sustained remission of suicidal ideation...